Mutations in the Nucleotide Binding Domain 1 Signature Motif Region Rescue Processing and Functional Defects of Cystic Fibrosis Transmembrane Conductance Regulator ΔF508

Autor: John L. Teem, Ana C. deCarvalho, Lisa J. Gansheroff
Rok vydání: 2002
Předmět:
Phenylalanine
Amino Acid Motifs
Blotting
Western

Genetic Vectors
Molecular Sequence Data
Cystic Fibrosis Transmembrane Conductance Regulator
ATP-binding cassette transporter
Biology
Transfection
Models
Biological

Biochemistry
Cystic fibrosis
Cell Line
Cyclic AMP
medicine
Animals
Humans
Amino Acid Sequence
ΔF508
Molecular Biology
Gene
Alleles
Dose-Response Relationship
Drug

Models
Genetic

Sequence Homology
Amino Acid

Colforsin
Wild type
Cell Biology
medicine.disease
Genistein
Molecular biology
Cystic fibrosis transmembrane conductance regulator
Protein Structure
Tertiary

Rats
Electrophysiology
Cyclic nucleotide-binding domain
Mutation
Mutagenesis
Site-Directed

Chloride channel
biology.protein
ATP-Binding Cassette Transporters
Electrophoresis
Polyacrylamide Gel

Chlorine
Gene Deletion
HeLa Cells
Plasmids
Zdroj: Journal of Biological Chemistry. 277:35896-35905
ISSN: 0021-9258
Popis: The gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR), an ATP binding cassette (ABC) transporter that functions as a phosphorylation- and nucleotide-regulated chloride channel, is mutated in cystic fibrosis (CF) patients. Deletion of a phenylalanine at amino acid position 508 (DeltaF508) in the first nucleotide binding domain (NBD1) is the most prevalent CF-causing mutation and results in defective protein processing and reduced CFTR function, leading to chloride impermeability in CF epithelia and heterologous systems. Using a STE6/CFTRDeltaF508 chimera system in yeast, we isolated two novel DeltaF508 revertant mutations, I539T and G550E, proximal to and within the conserved ABC signature motif of NBD1, respectively. Western blot and functional analysis in mammalian cells indicate that mutations I539T and G550E each partially rescue the CFTRDeltaF508 defect. Furthermore, a combination of both revertant mutations resulted in a 38-fold increase in CFTRDeltaF508-mediated chloride current, representing 29% of wild type channel activity. The G550E mutation increased the sensitivity of CFTRDeltaF508 and wild type CFTR to activation by cAMP agonists and blocked the enhancement of CFTRDeltaF508 channel activity by 2 mm 3-isobutyl-1-methylxanthine. The data show that the DeltaF508 defect can be significantly rescued by second-site mutations in the nucleotide binding domain 1 region, that includes the LSGGQ consensus motif.
Databáze: OpenAIRE